Home Stock

Stock Research: Chunghwa Chemical Synthesis & Biotech

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Chunghwa Chemical Synthesis & Biotech

TSEC:1762 TW0001762003
6
  • Value
    42
  • Growth
    10
  • Safety
    Safety
    41
  • Combined
    10
  • Sentiment
    18
  • 360° View
    360° View
    6
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

CHUNGHWA CHEMICAL SYNTHESIS & BIOTECH CO., LTD. is a Taiwan-based company manufacturing and distributing biotechnology and chemical synthetic products. The company's main businesses include biotechnology products (e.g., pravastatin, rapamycin, tacrolimus) and non-biotechnology products (e.g., methocarbamol, guaifenesin), applied in drugs for various treatments including cough, diabetes, cardiovascular diseases, high blood pressure, and immune system diseases. It operates in domestic and overseas markets, including Asia, the Americas, and Europe. In the last fiscal year, the company had a market cap of $73 million, profits of $12 million, and revenue of $41 million.

more
Strongest Rank Profit Growth
Weakest Rank Price vs. Book (P/B)
Country Taiwan
Industry Pharmaceuticals
Size X-Small
Website ccsb.com.tw
Index
FTSE Taiwan
Chunghwa Chemical Synthesis & Biotech stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 54 80 73
Growth
10 14 47 100
Safety
Safety
41 38 61 72
Sentiment
18 70 41 100
360° View
360° View
6 38 64 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
16 20 20 97
Opinions Change
50 50 50 50
Pro Holdings
n/a 52 30 98
Market Pulse
49 91 100 100
Sentiment
18 70 41 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
42 54 80 73
Growth
10 14 47 100
Safety Safety
41 38 61 72
Combined
10 13 79 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
5 26 97 95
Price vs. Earnings (P/E)
70 51 57 63
Price vs. Book (P/B)
95 83 65 63
Dividend Yield
30 64 67 65
Value
42 54 80 73
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
73 22 67 98
Profit Growth
4 28 15 26
Capital Growth
26 54 81 96
Stock Returns
10 16 39 91
Growth
10 14 47 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
35 33 47 94
Refinancing
80 63 57 27
Liquidity
14 31 61 61
Safety Safety
41 38 61 72

Similar Stocks

Discover high‑ranked alternatives to Chunghwa Chemical Synthesis & Biotech and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Shionogi

TSE:4507
Country: Japan
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Asustek Computer

TSEC:2357
Country: Taiwan
Industry: Technology Hardware & Peripherals
Size: Large
Full Stock Analysis

Ono Pharmaceutical

TSE:4528
Country: Japan
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews